Current Report Filing (8-k)
27 3월 2020 - 5:55AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 25, 2020 (March 25, 2020)
BALANCE
LABS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
333-202959
|
|
47-1146785
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
350
Lincoln Road, 4th Floor
(Address
of Principal Executive Offices)
Registrant’s
telephone number: (305) 907-7600
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act: None.
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Balance
Labs, Inc. (the “Company”) will be relying on the Securities and Exchange Commission’s Order under Section 36
of the Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder
dated March 4, 2020 (Release No. 34-88318) (the “Order”) to delay the filing of its Annual Report on Form 10-K for
the year ended December 31, 2019 (the “Report”) due to the circumstances related to COVID-19. In particular, COVID-19
has caused severe disruptions in transportation and limited access to the Company’s facilities resulting in limited support
from its staff and professional advisors. This has, in turn, delayed the Company’s ability to complete its audit and prepare
the Report. Notwithstanding the foregoing, the Company expects to file the Report no later than May 14, 2020 (which is 45 days
from the Report’s original filing deadline of March 30, 2020).
In
light of the current COVID-19 pandemic, the Company will be including the following Risk Factor into its Report:
An
occurrence of an uncontrollable event such as the COVID-19 pandemic is likely to negatively affect our operations.
The
occurrence of an uncontrollable event such as the COVID-19 pandemic is likely to negatively affect our operations. A pandemic
typically results in social distancing, travel bans and quarantine, and this has limited access to our facilities, customers,
management, support staff and professional advisors. These, in turn, will not only impact our operations, financial condition
and demand for our services but our overall ability to react timely to mitigate the impact of this event. Also, it may
substantially hamper our efforts to provide our investors with timely information and comply with our filing obligations with
the Securities and Exchange Commission.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Balance Labs, Inc.
|
|
|
|
Date:
March 26, 2020
|
|
|
|
|
|
|
/s/ Michael D. Farkas
|
|
Name:
|
Michael
D. Farkas
|
|
Title:
|
Chief
Executive Officer
|
Balance Labs (PK) (USOTC:BLNC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Balance Labs (PK) (USOTC:BLNC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Balance Labs Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Balance Labs, Inc. News Articles